2001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in Africa

A/RES/64/79No PDF available

Who created this mandate?

A Resolution of the General Assembly, under agenda item 472001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in Africa, published in 2010.

What other versions does this mandate have?

6 versions · 2003–2010

2010A/RES/64/792001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in AfricaLatestCompare with previous version
2008A/RES/62/1802001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in AfricaCompare with previous version
2006A/RES/60/2212001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in AfricaCompare with previous version
2005A/RES/59/2562001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in AfricaCompare with previous version
2004A/RES/58/2372001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in AfricaCompare with previous version

Versions are identified automatically by matching titles within the same organ (~97% accuracy on a manual audit).

What does this mandate say?

35 operative paragraphs

Welcomes the report prepared by the World Health Organization, and calls for support for the recommendations contained therein;

Encourages Member States, relevant organizations of the United Nations system, international institutions, non-governmental organizations, the private sector and civil society to continue to observe World Malaria Day and to collaborate in the observance of the final year of the Decade to Roll Back Malaria in Developing Countries, Particularly in Africa, in order to raise public awareness of and knowledge about the prevention, control and treatment of malaria as well as the importance of meeting the Millennium Development Goals;

Encourages the Special Envoy of the Secretary-General for Malaria to continue raising the issue in collaboration with other United Nations organizations already working on those issues on the international political and development agendas and to work with national and global leaders to help to secure the political will, the partnerships and the funds to drastically reduce malaria deaths by 2010 through increased access to protection and treatment, especially in Africa;

Welcomes the launch on 23 September 2009 in New York of the African Leaders Malaria Alliance to provide political leadership at the highest level in the fight against malaria in Africa;

Also welcomes the United Against Malaria campaign which aims at uniting football stars and teams, governmental and non-governmental organizations, foundations and corporations in the fight against malaria ahead of the 2010 International Federation of Association Football World Cup event, to be held in South Africa;

Further welcomes the increased funding for malaria interventions and for research and development of preventive and control tools from the international community, through funding from multilateral and bilateral sources and from the private sector, as well as by making predictable financing available through appropriate and effective aid modalities and in-country health financing mechanisms aligned with national priorities, which are key to strengthening health systems and promoting universal and equitable access to high-quality malaria prevention and treatment services;

Urges the international community, together with United Nations agencies and private organizations and foundations, to support the implementation of the Global Malaria Action Plan, including through support for programmes and activities at the country level in order to achieve internationally agreed targets on malaria;

Calls upon the international community to continue to support the secretariat of the Roll Back Malaria Partnership and partner organizations, including the World Health Organization, the World Bank and the United Nations Children’s Fund, as vital complementary sources of support for the efforts of malaria-endemic countries to combat the disease;

Appeals to the international community to work in a spirit of cooperation towards effective, increased, harmonized and sustained bilateral and multilateral assistance to combat malaria, including support for the Global Fund to Fight AIDS, Tuberculosis and Malaria, in order to assist States, in particular malaria-endemic countries, to implement sound national plans, in particular health plans and sanitation plans, including malaria control strategies and integrated management of childhood illnesses, in a sustained and equitable way that, inter alia, contributes to health system development;

Appeals to the malaria partners to resolve the financial and delivery bottlenecks that are responsible for stock-outs of long-lasting insecticide-treated nets, artemisinin-based combination therapies and rapid diagnostic tests at the national level, whenever they occur, including through the strengthening of malaria programme management at the country level;

Welcomes the contribution to the mobilization of additional and predictable resources for development by voluntary innovative financing initiatives taken by groups of Member States, and in this regard notes the International Drug Purchase Facility, UNITAID, the International Finance Facility for Immunization, the Affordable Medicines Facility for Malaria, the Global Alliance for Vaccines and Immunization, the advance market commitment initiatives and the work of the High-level Task Force on Innovative International Financing for Health Systems;

Urges malaria-endemic countries to work towards financial sustainability, to increase, to the extent possible, domestic resource allocation to malaria control and to create favourable conditions for working with the private sector in order to improve access to good-quality malaria services;

Urges Member States to assess and respond to the needs for integrated human resources at all levels of the health system, in order to achieve the targets of the Abuja Declaration on Roll Back Malaria in Africa4 and the internationally agreed development goals, including the Millennium Development Goals, to take actions, as appropriate, to effectively govern the recruitment, training and retention of skilled health personnel, and to give particular focus to the availability of skilled personnel at all levels to meet technical and operational needs as increased funding for malaria control programmes becomes available;

Calls upon the international community, inter alia, by helping to meet the financial needs of the Global Fund to Fight AIDS, Tuberculosis and Malaria and through country-led initiatives with adequate international support, to intensify access to affordable, safe and effective antimalarial combination treatments, intermittent preventive treatment in pregnancies, adequate diagnostic facilities, long-lasting insecticide-treated mosquito nets, including, where appropriate, through the free distribution of such nets and, where appropriate, to insecticides for indoor residual spraying for malaria control, taking into account relevant international rules, including the Stockholm Convention on Persistent Organic Pollutants standards and guidelines;

Requests relevant international organizations, in particular the World Health Organization and the United Nations Children’s Fund, to assist efforts of national Governments to provide universal access to malaria control interventions especially to address at-risk young children and pregnant women in malaria-endemic countries, particularly in Africa, as rapidly as possible, with due regard to ensuring proper use of those interventions, including long-lasting insecticide nets, and sustainability through full community participation and implementation through the health system;

Calls upon Member States, in particular malaria-endemic countries, with the support of the international community, to establish and/or strengthen national policies and operational plans, with a view to scaling up efforts to achieve internationally agreed malaria targets for 2010 and 2015, in accordance with the technical recommendations of the World Health Organization;

Encourages all African countries that have not yet done so to implement the recommendations of the Abuja Summit in 2000 to reduce or waive taxes and tariffs for nets and other products needed for malaria control,Error: Reference source not found both to reduce the price of the products to consumers and to stimulate free trade in those products;

Calls upon United Nations agencies and their partners to continue to provide the technical support necessary to build and enhance the capacity of Member States to implement the Global Malaria Action Plan and meet the internationally agreed goals, including the Millennium Development Goals;

Expresses its concern about the increase in resistant strains of malaria in several regions of the world, and calls upon Member States, with support from the World Health Organization and other partners, to strengthen surveillance systems for drug and insecticide resistance and upon the World Health Organization to coordinate a global network for the monitoring of drug and insecticide resistance and to ensure that drug and insecticide testing is fully operational in order to enhance the use of current insecticide- and artemisinin-based combination therapies;

Urges all Member States experiencing resistance to conventional monotherapies to replace them with combination therapies, as recommended by the World Health Organization, and to develop the necessary financial, legislative and regulatory mechanisms in order to introduce artemisinin combination therapies at affordable prices and to prohibit the marketing of oral artemisinin monotherapies, in a timely manner;

Recognizes the importance of the development of safe and cost-effective vaccines and new medicines to prevent and treat malaria and the need for further and accelerated research, including into safe, effective and high-quality traditional therapies, using rigorous standards, including by providing support to the Special Programme for Research and Training in Tropical Diseases and through effective global partnerships, such as the various malaria vaccine initiatives and the Medicines for Malaria Venture, where necessary stimulated by new incentives to secure their development and through effective and timely support towards pre-qualification of new antimalarials and their combinations;

Calls upon the international community, including through existing partnerships, to increase investment in and efforts towards the research and development of new, safe and affordable malaria-related medicines, products and technologies, such as vaccines, rapid diagnostic tests, insecticides and delivery modes, to prevent and treat malaria, especially for at-risk children and pregnant women, in order to enhance effectiveness and delay the onset of resistance;

Calls upon malaria-endemic countries to assure favourable conditions for research institutions, including allocation of adequate resources and development of national policies and legal frameworks, where appropriate, with a view to, inter alia, informing policy formulation and strategic interventions on malaria;

Reaffirms the right to use, to the fullest extent, the provisions contained in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), the Doha Declaration on the TRIPS Agreement and Public Health, the decision of the World Trade Organization’s General Council of 30 August 2003 and amendments to article 31 of the Agreement, which provide flexibilities for the protection of public health, and in particular to promote access to medicines for all, including the production, under compulsory licensing, of generic drugs in the prevention and treatment of malaria, and resolves to assist developing countries in this regard;

Calls upon the international community to support ways to expand access to and the affordability of key products, such as vector control measures, including indoor residual spraying, long-lasting insecticide-treated nets and artemisinin-based combination therapy for populations at risk of exposure to resistant strains of falciparum malaria in malaria-endemic countries, particularly in Africa, including through additional funds and innovative mechanisms, inter alia, for the financing and scaling up of artemisinin production and procurement, as appropriate, to meet the increased need;

Welcomes the increased level of public-private partnerships for malaria control and prevention, including the financial and in-kind contributions of private sector partners and companies operating in Africa, as well as the increased engagement of non-governmental service providers;

Encourages the producers of long-lasting insecticide-treated nets to accelerate technology transfer to developing countries, and invites the World Bank and regional development funds to consider supporting malaria-endemic countries in establishing factories to scale up production of long-lasting insecticide-treated nets;

Calls upon the international community and malaria-endemic countries, in accordance with existing guidelines and recommendations of the World Health Organization and the requirements of the Stockholm Convention, to increase capacity for the safe, effective and judicious use of indoor residual spraying and other forms of vector control and for quality control measures to ensure conformity with international rules, standards and guidelines;

Urges the international community to become fully knowledgeable about World Health Organization technical policies and strategies and the provisions in the Stockholm Convention related to the use of DDT, including for indoor residual spraying, long-lasting insecticide-treated nets and case management, intermittent preventive treatment for pregnant women and monitoring of in vivo resistance studies to artemisinin-based combination therapy treatment, so that projects support those policies, strategies and provisions;

Requests the World Health Organization, the United Nations Children’s Fund and donor agencies to provide support to those countries which choose to use DDT for indoor residual spraying so as to ensure that it is implemented in accordance with international rules, standards and guidelines, and to provide all possible support to malaria-endemic countries to manage the intervention effectively and prevent the contamination, in particular, of agricultural products with DDT and other insecticides used for indoor residual spraying;

Encourages the World Health Organization and its member States, with the support of the parties to the Stockholm Convention, to continue to explore possible alternatives to DDT as a vector control agent;

Calls upon malaria-endemic countries to encourage regional and intersectoral collaboration, both public and private, at all levels, especially in education, health, agriculture, economic development and the environment, to advance malaria control objectives;

Calls upon the international community to support the strengthening of health systems and national pharmaceutical policies, to monitor and fight against the trade in counterfeit antimalarial medicines and prevent their distribution and use, and to support coordinated efforts, inter alia, by providing technical assistance to improve surveillance, monitoring and evaluation systems and their alignment with national plans and systems so as to better track and report changes in coverage, the need for scaling up recommended interventions and the subsequent reductions in the burden of malaria;

Urges Member States, the international community and all relevant actors, including the private sector, to promote the coordinated implementation and enhance the quality of malaria-related activities, including via the Roll Back Malaria Partnership, in accordance with national policies and operational plans that are consistent with the technical recommendations of the World Health Organization and recent efforts and initiatives, including, where appropriate, the Paris Declaration on Aid Effectiveness and the Accra Agenda for Action, adopted during the Third High-level Forum on Aid Effectiveness, held in Accra from 2 to 4 September 2008;

Notes that the 2010 High-level Plenary Meeting of the sixty-fifth session of the General Assembly will provide an opportunity to review progress in achieving the Millennium Development Goals, and requests the Secretary-General, in close collaboration with the Director-General of the World Health Organization and in consultation with Member States, to submit to the Assembly at its sixty-fifth session a report on progress towards achieving the internationally agreed targets for 2010 and an evaluation of the implementation of the first Decade to Roll Back Malaria in Developing Countries, Particularly in Africa, including recommendations for further actions.

Paragraph content is machine-extracted from UN documents. For authoritative content, please refer to the official UN document.

No headings found in this document.

2001-2010 : Decade to Roll Back Malaria in Developing Countries, Particularly in Africa

Who created this mandate?

What other versions does this mandate have?

What subjects does this mandate have?

What does this mandate say?

Table of contents